Výsledky vyhledávání - Paul M. Moseley
- Zobrazuji výsledky 1 - 11 z 11
-
1
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuv... Autor T. M. A. Abdel-Fatah, Christina J. Perry, P. Dickinson, Graham Ball, Paul M. Moseley, Srinivasan Madhusudan, Ian O. Ellis, Stephen Chan
Vydáno 2013Artigo -
2
Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells Autor Rebeka Sultana, Tarek M.A. Abdel-Fatah, Christina J. Perry, Paul M. Moseley, Nada Albarakti, Vivek Chandra mohan, Claire Seedhouse, Stephen Chan, Srinivasan Madhusudan
Vydáno 2013Artigo -
3
ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers Autor Tarek M.A. Abdel-Fatah, Arvind Arora, Paul M. Moseley, Clare Coveney, Christina J. Perry, Kerstie Johnson, Christopher Kent, Graham Ball, Stephen Chan, Srinivasan Madhusudan
Vydáno 2014Artigo -
4
Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse... Autor Gemma A. Foulds, Jayakumar Vadakekolathu, Tarek M.A. Abdel-Fatah, Divya Nagarajan, Stephen Reeder, Catherine Johnson, Simon Hood, Paul M. Moseley, Stephen Chan, A. Graham Pockley, Sergio Rutella, Stéphanie McArdle
Vydáno 2018Artigo -
5
Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer Autor Arvind Arora, Tarek M. Abdel-Fatah, Devika Agarwal, Rachel Doherty, Paul M. Moseley, Mohammed A. Aleskandarany, Andrew R. Green, Graham Ball, Alaa T. Alshareeda, Emad A. Rakha, Stephen Chan, Ian O. Ellis, Srinivasan Madhusudan
Vydáno 2015Artigo -
6
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis Autor Tarek M.A. Abdel-Fatah, Devika Agarwal, Dongxu Liu, Roslin Russell, Oscar M. Rueda, Karen Liu, Bing Xu, Paul M. Moseley, Andrew R. Green, A. Graham Pockley, Robert C. Rees, Carlos Caldas, Ian O. Ellis, Graham Ball, Stephen Chan
Vydáno 2016Artigo -
7
Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer Autor Tarek M.A. Abdel-Fatah, Fiona K. Middleton, Arvind Arora, Devika Agarwal, Tao Chen, Paul M. Moseley, Christina J. Perry, Rachel Doherty, Stephen Chan, Andrew R. Green, Emad A. Rakha, Graham Ball, Ian O. Ellis, Nicola J. Curtin, Srinivasan Madhusudan
Vydáno 2014Artigo -
8
Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy Autor Nada Albarakati, Tarek M.A. Abdel-Fatah, Rachel Doherty, Roslin Russell, Devika Agarwal, Paul M. Moseley, Christina J. Perry, Arvind Arora, Nouf H. Alsubhi, Claire Seedhouse, Emad A. Rakha, Andrew R. Green, Graham Ball, Stephen Chan, Carlos Caldas, Ian O. Ellis, Srinivasan Madhusudan
Vydáno 2014Artigo -
9
<scp>RECQL4</scp> helicase has oncogenic potential in sporadic breast cancers Autor Arvind Arora, Devika Agarwal, Tarek MA Abdel‐Fatah, Huiming Lu, Deborah L. Croteau, Paul M. Moseley, Mohammed A. Aleskandarany, Andrew R. Green, Graham Ball, Emad A. Rakha, Stephen Chan, Ian O. Ellis, Lisa L. Wang, Yongliang Zhao, Adayabalam S. Balajee, Vilhelm A. Bohr, Srinivasan Madhusudan
Vydáno 2015Artigo -
10
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer Autor Kalnisha Naidoo, Patty T. Wai, Sarah Maguire, Frances Daley, Syed Haider, Divya Kriplani, James Campbell, Hasan Mirza, Anita Grigoriadis, Andrew Tutt, Paul M. Moseley, Tarek M.A. Abdel-Fatah, Stephen Chan, Srinivasan Madhusudan, Emad A. Rhaka, Ian O. Ellis, Christopher J. Lord, Yinyin Yuan, Andrew R. Green, Rachael Natrajan
Vydáno 2018Artigo -
11
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer Autor Tarek M. Abdel-Fatah, Roslin Russell, Nada Albarakati, David J. Maloney, Dorjbal Dorjsuren, Oscar M. Rueda, Paul M. Moseley, Vivek Mohan, Hongmao Sun, Rachel Abbotts, Abhik Mukherjee, Devika Agarwal, Jennifer L. Illuzzi, Ajit Jadhav, Anton Simeonov, Graham Ball, Stephen Chan, Carlos Caldas, Ian O. Ellis, David M. Wilson, Srinivasan Madhusudan
Vydáno 2014Artigo
Vyhledávací nástroje:
Související témata
Cancer
Biology
Cancer research
Medicine
Breast cancer
Internal medicine
Genetics
Oncology
Gene
Cell cycle
DNA
DNA damage
Chemotherapy
DNA repair
Molecular biology
Biochemistry
CHEK1
Cell cycle checkpoint
Cisplatin
DNA-PKcs
Genotype
Helicase
Pathology
RNA
Single-nucleotide polymorphism
Synthetic lethality
Triple-negative breast cancer
XRCC1
Adjuvant
Adjuvant therapy